National Peroxide Q2FY27: revenue +64% YoY, but margin collapse sinks PAT 87% QoQ
PAT +125.6% YoY · revenue +64.07% · margins compressing
₹112.04 Cr
+64.07% YoY
₹0.87 Cr
+125.6% YoY
0.76%
+0.2pp YoY
₹1.51
National Peroxide's standalone revenue rose 64.1% YoY to ₹112.04 Cr (and +16.6% QoQ from ₹96.07 Cr in Q1FY27), but profit after tax of just ₹0.87 Cr tells a much weaker story than the topline suggests. PAT is up nominally from a thin ₹0.39 Cr a year ago, but that YoY comparison is off a near-zero base and is dwarfed by the sequential collapse — PAT fell 86.8% quarter-on-quarter from ₹6.61 Cr in Q1FY27, even as revenue grew. There were no exceptional items in either the current or year-ago quarter, so this is a clean, like-for-like comparison, not a one-off distortion.
Q2 FY-2027 vs prior quarters
The real story is margin compression on the operating line: OPM nearly halved to 4.46% from 6.59% a year ago, and fell sharply from 12.74% in Q1FY27 — cost of raw materials and packing materials consumed rose to ₹59.47 Cr from ₹52.99 Cr sequentially, outpacing the revenue increase. Net margin actually ticked up YoY (0.78% vs 0.55%) only because lower finance costs (₹0.24 Cr vs ₹0.35 Cr) cushioned the thin operating profit against last year's even thinner base — it still fell steeply from 6.73% in Q1FY27. Effective tax rate was ~25.2%, unremarkable.
The stock went into the print at ₹543, down 7.4% over the past month of trading.
There is no management guidance or prior concall commentary on record to grade this print against, and no formal management press release accompanied this filing beyond the routine board-outcome letter — management gives no outlook to assess met/missed. No analyst previews or consensus estimates for this quarter turned up in a search, consistent with this being a thinly covered micro-cap (vsStreet unknown). The results coincide with corporate change: Vinay Jayade, appointed CEO effective October 1, 2026 after Rajiv Arora's resignation, signed this result as CEO & Director, and the board separately approved Amit Shah as Head–Sales & Marketing the same day — neither development has numbers attached yet but both land right as the cost base is under pressure.
W1
Whether OPM recovers toward the 12.74% seen in Q1FY27 or stays compressed near the current 4.46% — no cost-driver commentary accompanied this filing
W2
Execution under new CEO Vinay Jayade and new sales head Amit Shah in the next 1-2 quarters
W3
Raw material cost trajectory — consumption cost rose to ₹59.47 Cr this quarter from ₹52.99 Cr in Q1FY27, a faster pace than revenue growth
Standalone-only filing (no consolidated section); raw PDF text-extraction scrambled the table's column order but every cross-check (Total Income, Total Expenses, HY=Q1+Q2, PBT-tax=PAT) ties out exactly against the given column headers, so figures are reliable. A ₹0.58 Cr exceptional item appears only in the FY26 annual column, not in either quarter being compared, so YoY/QoQ are like-for-like.